Related Experiment Video
Updated: Aug 25, 2025

Xenopus laevis as a Model to Identify Translation Impairment
Published on: September 27, 2015
DDX60 selectively reduces translation off viral type II internal ribosome entry sites
Mohammad Sadic1, William M Schneider2, Olga Katsara1
1NYU Grossman School of Medicine, New York, NY, USA.
Abstract:
Co-opting host cell protein synthesis is a hallmark of many virus infections. In response, certain host defense proteins limit mRNA translation globally, albeit at the cost of the host cell's own protein synthesis. Here, we describe an interferon-stimulated helicase, DDX60, that decreases translation from viral internal ribosome entry sites (IRESs). DDX60 acts selectively on type II IRESs of encephalomyocarditis virus (EMCV) and foot and mouth disease virus (FMDV), but not by other IRES types or by 5' cap. Correspondingly, DDX60 reduces EMCV and FMDV (type II IRES) replication, but not that of poliovirus or bovine enterovirus 1 (BEV-1; type I IRES). Furthermore, replacing the IRES of poliovirus with a type II IRES is sufficient for DDX60 to inhibit viral replication. Finally, DDX60 selectively modulates the amount of translating ribosomes on viral and in vitro transcribed type II IRES mRNAs, but not 5' capped mRNA. Our study identifies a novel facet in the repertoire of interferon-stimulated effector genes, the selective downregulation of translation from viral type II IRES elements.
Insights
Interferon-stimulated protein DDX60 selectively inhibits viral replication by reducing translation from specific viral RNA structures called type II internal ribosome entry sites (IRESs). This antiviral mechanism targets viral protein synthesis without broadly affecting host cell translation.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Viruses hijack host protein synthesis for replication.
- Host defense mechanisms often globally inhibit mRNA translation, impacting host cells.
- Interferon-stimulated genes play a crucial role in antiviral immunity.
Purpose of the Study:
- To identify and characterize host factors that selectively inhibit viral translation.
- To investigate the role of the interferon-stimulated helicase DDX60 in antiviral defense.
- To elucidate the mechanism by which DDX60 restricts viral replication.
Main Methods:
- Investigated the effect of DDX60 on translation from different types of internal ribosome entry sites (IRESs).
- Assessed viral replication of encephalomyocarditis virus (EMCV), foot and mouth disease virus (FMDV), poliovirus, and bovine enterovirus 1 (BEV-1) in the presence of DDX60.
- Analyzed ribosome occupancy on viral IRES and 5' cap-dependent mRNAs.
Main Results:
- DDX60 selectively inhibits translation from type II IRESs (EMCV, FMDV), but not other IRES types or 5' cap-dependent translation.
- DDX60 reduces the replication of viruses utilizing type II IRESs (EMCV, FMDV), but not those with type I IRESs (poliovirus, BEV-1).
- Replacing poliovirus IRES with a type II IRES rendered it sensitive to DDX60 inhibition.
- DDX60 modulates ribosome loading specifically on type II IRES mRNAs.
Conclusions:
- DDX60 is an interferon-stimulated gene product that acts as a selective antiviral factor.
- DDX60 inhibits viral replication by downregulating translation initiated from type II IRES elements.
- This study reveals a novel mechanism of innate antiviral immunity targeting specific viral RNA structures.
Related Concept Videos
Leaky Scanning
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Improving Translational Accuracy
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

